---
title: 'Infection risk and antimicrobial prophylaxis in bendamustine-treated patients
  with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study'
date: '2024-03-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38485116/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240315180616&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Infection and lymphopenia are established bendamustine-related complications.
  The relationship between lymphopenia severity and infection risk, and the role of
  antimicrobial prophylaxis, is not well described. This multicentre retrospective
  study analysed infection characteristics and antimicrobial prophylaxis in 302 bendamustine-treated
  indolent non-Hodgkin lymphoma patients. Lymphopenia (<1 × 10⁹ /L) was near universal
  and time to lymphocyte recovery correlated with cumulative ...
disable_comments: true
---
Infection and lymphopenia are established bendamustine-related complications. The relationship between lymphopenia severity and infection risk, and the role of antimicrobial prophylaxis, is not well described. This multicentre retrospective study analysed infection characteristics and antimicrobial prophylaxis in 302 bendamustine-treated indolent non-Hodgkin lymphoma patients. Lymphopenia (<1 × 10⁹ /L) was near universal and time to lymphocyte recovery correlated with cumulative ...